Interaction of calbindin D28k and inositol monophosphatase in human postmortem cortex: Possible implications for bipolar disorder

Bipolar Disorders

Volumn 7, Issue 1, 2005, Pages 42-48

  Shamir, Alon ^a   Elhadad Rosolio, Naama ^a   Belmaker, Robert H ^a   Agam, Galila ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Bipolar disorder; Calbindin D28k; Inositol monophosphatase; Lithium; Postmortem brain; Protein levels

Indexed keywords

CALBINDIN; INOSITOL MONOPHOSPHATASE; LITHIUM CHLORIDE; PHOSPHATASE; UNCLASSIFIED DRUG; LITHIUM CARBONATE; MYO INOSITOL 1 (OR 4) MONOPHOSPHATASE; MYO-INOSITOL-1 (OR 4)-MONOPHOSPHATASE; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BIPOLAR DISORDER; BRAIN CORTEX; BRAIN HOMOGENATE; BRAIN LEVEL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM CARE; LYMPHOCYTE; MAJOR DEPRESSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; SPECTROPHOTOMETRY; TEMPORAL CORTEX; WESTERN BLOTTING; ANIMAL; ENZYMOLOGY; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM;

ANIMALS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CEREBRAL CORTEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LITHIUM CARBONATE; LYMPHOCYTES; MALE; MICE; MICE, INBRED ICR; PHOSPHORIC MONOESTER HYDROLASES;

EID: 13644256425     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2004.00162.x     Document Type: Article

References (31)

1. Gould TD, Manji HK. Signaling networks in the pathophysiology and treatment of mood disorders. J Psychosom Res 2002; 53: 687-697.
2. Sjoholt G, Molven A, Lovlie R, Wilcox A, Sikela JM, Steen VM. Genomic structure and chromosomal localization of a human myo-inositol monophosphatase gene (IMPA). Genomics 1997; 45: 113-122.
3. Sjoholt G, Gulbrandsen AK, Lovlie R, Berle J, Molven A, Steen VM. A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients. Mol Psychiatry 2000; 5: 172-180.
4. Yoshikawa T, Padigaru M, Karkera JD et al. Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2). Mol Psychiatry 2000; 5: 165-171.
5. Berridge MJ, Downes CP, Hanley MR. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 1982; 206: 587-595.
6. Shamir A, Ebstein RP, Nemanov L, Zohar A, Belmaker RH, Agam G. Inositol monophosphatase in immortalized lymphoblastoid cell lines indicates susceptibility to bipolar disorder and response to lithium therapy. Mol Psychiatry 1998; 3: 481-482.
7. Shaltiel G, Shamir A, Nemanov L et al. Inositol monophosphatase activity in brain and lymphocyte-derived cell lines of bipolar, schizophrenic and unipolar patients. World J Biol Psychiatry 2001; 2: 95-98.
8. Shimon H, Agam G, Belmaker RH, Hyde TM, Kleinman JE. Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am J Psychiatry 1997; 154: 1148-1150.
9. Berggard T, Szczepankiewicz O, Thulin E, Linse S. Myo-inositol monophosphatase is an activated target of calbindin D28k. J Biol Chem 2002; 277: 41954-41959.
10. Iritani S, Niizato K, Emson PC. Relationship of calbindin D28K-immunoreactive cells and neuropathological changes in the hippocampal formation of Alzheimer's disease. Neuropathology 2001; 21: 162-167.
11. Gonzalez-Albo MC, Elston GN, DeFelipe J. The human temporal cortex: characterization of neurons expressing nitric oxide synthase, neuropeptides and calcium-binding proteins, and their glutamate receptor subunit profiles. Cereb Cortex 2001; 11: 1170-1181.
12. Cotter D, Landau S, Beasley C et al. The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol Psychiatry 2002; 51: 377-386.
13. Mikkonen M, Soininen H, Pitkanen A. Distribution of parvalbumin-, calretinin-, and calbindin-D28k-immunoreactive neurons and fibers in the human entorhinal cortex. J Comp Neurol 1997; 388: 64-88.
14. Beasley CL, Zhang ZJ, Patten I, Reynolds GP. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiatry 2002; 52: 708-715.
15. Morishima K, Matsuura S, Tauchi H, Nakamura A, Komatsu K. A polymorphic CA repeat marker at the human 27-kD calbindin (CALB1) locus. J Hum Genet 1999; 44: 414-415.
16. Parmentier M, Passage E, Vassart G, Mattei MG. The human calbindin D28k (CALB1) and calretinin (CALB2) genes are located at 8q21.3-q22.1 and 16q22-q23, respectively, suggesting a common duplication with the carbonic anhydrase isozyme loci. Cytogenet Cell Genet 1991; 57: 41-43.
17. Mattson MP, Rychlik B, Chu C, Christakos S. Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons. Neuron 1991; 6: 41-51.
18. Nagerl UV, Mody I, Jeub M, Lie AA, Elger CE, Beck H. Surviving granule cells of the sclerotic human hippocampus have reduced Ca(2+) influx because of a loss of calbindin-D(28k) in temporal lobe epilepsy. J Neurosci 2000; 20: 1831-1836.
19. Yenari MA, Minami M, Sun GH et al. Calbindin d28k overexpression protects striatal neurons from transient focal cerebral ischemia. Stroke 2001; 32: 1028-1035.
20. Council NR (ed.). Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press, 1996.
21. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The Stanley foundation brain collection and neuropathology consortium. Schizophr Res 2000; 44: 151-155.
22. de Rock E, Taylor N. An easy method of layering blood over Ficoll-Paque gradients. J Immunol Methods 1977; 17: 373-374.
23. McCauley I, Hartmann PE. The estimation of B lymphocytes and their subpopulations in pigs. A comparison between a method using whole blood and one using Ficoll-Paque purified mononuclear cells. J Immunol Methods 1982; 50: 33-38.
24. Nemanov L, Ebstein RP, Shamir A, Etack JR, Belmaker RH, Agam G. Effect of Affective Disorders and Lithium Treatment on Inositol Monophosphatase Transcription and Translation. Cheshire, Connecticut: Weinder Publishing group, 1999.
25. Atack JR, Broughton HB, Pollack SJ. Inositol monophosphatase - a putative target for Li+ in the treatment of bipolar disorder. Trends Neurosci 1995; 18: 343-349.
26. Kozlovsky N, Belmaker RH, Agam G. Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients. Am J Psychiatry 2000; 157: 831-833.
27. Allison JH, Blisner ME, Holland WH, Hipps PP, Sherman WR. Increased brain myo-inositol 1-phosphate in lithium-treated rats. Biochem Biophys Res Commun 1976; 71: 664-670.
28. Perkel JM. Validating the interactome. Scientist 2004; 18: 19-22.
29. Figeys D. Combining different 'omics' technologies to map and validate protein-protein interactions in humans. Brief Funct Genomic Proteomic 2004; 2: 357-365.
30. Sjoholt G, Ebstein RP, Lie RT et al. Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder. Mol Psychiatry 2004; 9: 621-629.
31. Yuan ZQ, Gottlieb B, Beitel LK et al. Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms. Hum Mutat 2002; 19: 108-113.